Combination therapy • Trial completion date • Trial primary completion date • Enrollment closed • Metastases
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog) • PI3K (Phosphoinositide 3-kinases)
|
EGFR mutation • BRAF mutation • NRAS mutation • BRAF V600 • KRAS G13D • RAS mutation • BRAF fusion • KRAS G13 • NRAS G13
|
FoundationOne® CDx
|
Erbitux (cetuximab) • Cotellic (cobimetinib) • belvarafenib (RG6185)